2m 2m 2m 2m 2m 2m 2m
LENSAR (LNSR)
NASDAQ
$6.06+$0.36 (+6.41%)
Price as of Oct 22, 2026 7:30 PM EDT- $69.9MMarket Cap
- -53.44%1-Year Change
- Medical DevicesIndustry
LENSAR (LNSR)
$6.06+$0.36 (+6.41%)
LNSR | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $5.69 | ||
Change | -$0.12 (-2.07%) | ||
Open | $5.77 | ||
High | $5.83 | ||
Low | $5.68 | ||
Previous Close | $5.81 | ||
Volume | 29,444 | ||
30-Day Average Volume | 39,367 | ||
1-Week Change | -6.87% | ||
1-Month Change | -21.08% | ||
1-Year Change | -53.44% | ||
3-Year Change | 149.56% | ||
5-Year Change | -25.13% | ||
Fundamentals | |||
Shares Outstanding | 12.3M | ||
Total Assets | $69.6M | ||
Market Cap | $69.9M | ||
Enterprise Value | $70.1M | ||
Period: QTR TTM FY | |||
Revenue | $16.5M | ||
Net Income | $3.5M | ||
Free Cash Flow | -$156,000.00 | ||
EBIT | $3.5M | ||
EBITDA | $3.8M | ||
Net Working Capital | $27.4M | ||
EPS | $0.10 | ||
Enterprise Value/EBITDA | 19 | ||
Enterprise Value/Revenue | 4 | ||
P/B | 5 | ||
P/E | 57 | ||
PEG | N/A | ||
Price/Free Cash Flow | -448 | ||
Price/Operating Cash Flow | -550 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue